Skip to main content

North American Nuclear Medicine Market To Reach USD 2.7 Billion By 2024 – Expansion In Emerging Economies

 What This Report Will Provide?

The study involved four major activities in estimating the current size for the North American nuclear medicine market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Expected Revenue Growth:

[159 Pages Report] The North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period.

Major Growth Boosters:

Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.

Download PDF Brochure: Download PDF Brochure - North American Nuclear Medicine Market - Global Forecast to 2024 | MarketsandMarkets

Key Questions Addressed in The Report:

  • Which product segment will dominate the North American nuclear medicine market in the future?
  • Which application segment will dominate the market in the future?
  • Emerging countries offer immense opportunities for the growth and adoption of nuclear medicine; will this scenario continue in the coming five years?
  • Where will technology advancements offered by various companies take the industry in the mid- to long-term?
  • What are the upcoming products in the nuclear medicine market?

The alpha emitters segment is expected to command the largest share of the therapeutic nuclear medicine market in 2019

Based on type, the market is categorized into diagnostic and therapeutic nuclear medicine. The therapeutic nuclear medicine segment is further segmented into alpha emitters, beta emitters, and brachytherapy isotopes. In 2013, the FDA approved the first and only product for alpha emitters in the market, launched by Bayer AG under the name Xofigo (a Ra-223 dichloride molecule). The North American market for Ra-223 is expected to command the largest share owing to its targeted properties over beta emitters and being the only alpha-emitter product available in the market.

Request Sample Report: Sample Request - North American Nuclear Medicine Market - Global Forecast to 2024 | MarketsandMarkets

On the basis of type, which segment will command the largest market share?On the basis of type, North America nuclear medicine market is segmented into diagnostic and therapeutic North America nuclear medicine. The diagnostic North America nuclear medicine market accounted for the largest share of the North America nuclear medicine market. The rising prevalence of cancer and cardiovascular diseases, increasing use of SPECT and PET imaging and advancements in radiotracers are driving the growth of this segment.

Regional Growth Analysis:

Geographically, the North American market comprises of US and Canada. In 2018, the US accounted for the largest share of the nuclear medicine market. The large share can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the country.

Labels:

Comments

Post a Comment

Popular posts from this blog

Inspection Machines Market To Reach USD 871 Million By 2025 - Growing Demand For Personalized Medicine

  What This Report Will Provide? This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies. Expected Revenue Growth: The  Inspection machines market  is projected to reach USD 871 million by 2025 from USD 671 million in 2020, at a CAGR of 5.4% during the forecast period. Major Growth Boosters: The growth of this market is majorly driven as companies are now increasingly adopting inspection systems throughout their production lines due to the growing concerns to the regulatory mandates introduced by the government and regulatory bodies in the healthcare industry to maintain compliance with Good Manufacturing Practices ( GMP ). Download PDF Brochure:    https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81453085   COVID-19 Impact on the  Inspection M
Post a Comment
Read more

APAC is projected to be the fastest-growing High Performance Bioinformatics Market

According to the new market research report “ Bioinformatics Platforms Market  by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) – Global Forecast to 2023″, , published by MarketsandMarkets™ ,The global bioinformatics market is expected to account for USD 7,063.7 billion in 2018. It is expected to reach USD 13,901.5 billion by 2023, at a CAGR of 14.5% during the forecast period. Browse in-depth TOC on “Bioinformatics Market 189 – Tables 27 – Figures 195 – Pages Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39 Growth of the bioinformatics Platforms Market is driven by the growing demand for nucleic acid and protein sequencing, increasing government initiatives and funding, and increasing use of bioinformatics in drug discovery and biomarker development processes. With the introducti
Post a Comment
Read more

Benefits of Best Accounting Software by 360Quadrants

  Accounting software  can manage the businesses in several different ways, based on the key characteristics and goals. Accounting systems provide all kinds of bonuses, from simpler invoicing to complicated tax reporting, that is not even possible without a correct framework. Simplification  - Accounting software put control of funds in the hands of a non-accounting crowd, aimed at giving significance to statistics while executing electronic computations. With hardly any training, the company owner can execute all financial transactions and meet the legal requirements from a desktop computer or smartphone, even without having to pay a third party to keep the expenditure in the loop. Cost reduction  - Accounting and finance frameworks simplify key estimates and operating processes and gain a charge of the sales process and you don't need to outsource financial services to an external specialist. They also raise printing and storage prices and store confidential data is safe and cont
Post a Comment
Read more